Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations

European Journal of Epidemiology

Volumn 27, Issue 5, 2012, Pages 379-384

  Rossi, Isabelle Anne ^a   Bochud, Murielle ^a   Bovet, Pascal ^a,b   Paccaud, Fred ^a   Waeber, Gérard ^c   Vollenweider, Peter ^c   Taffé, Patrick ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b MINISTRY OF HEALTH   (Seychelles)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Africa; Body mass index; C reactive protein; Fat mass; Obesity

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; LEPTIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NEGRO; OBESITY; PHYSICAL ACTIVITY; SEX DIFFERENCE; SEYCHELLES; SMOKING; SWITZERLAND;

ADIPOSITY; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; LEPTIN; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SEX FACTORS; SEYCHELLES; SWITZERLAND;

EID: 84863715483     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9671-0     Document Type: Article

References (37)

1. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-Aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2):237-42.
2. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105(22):2595-9.
3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557-65.
4. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-97.
5. Ridker PM. High-sensitivity C-reactive protein as a predictor of all-cause mortality: Implications for research and patient care. Clin Chem. 2008;54(2):234-7.
6. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham study. Stroke. 2001;32(11):2575-9.
7. Kaptoge S, Di AE, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-Analysis. Lancet. 2010;375(9709):132-40.
8. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42-7.
9. Ford ES. Body mass index, diabetes, and C-reactive protein among US adults. Diabetes Care. 1999;22(12):1971-7.
10. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972-8.
11. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middleaged men. Diabetologia. 2004;47(8):1403-10.
12. Wong ND, Pio J, Valencia R, Thakal G. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol. 2001;4(3): 109-14.
13. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-Aged women. Arterioscler Thromb Vasc Biol. 1999;19(8):1986-91.
14. Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407-15.
15. Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich- Horvat P, Larson MG, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress-The Framingham heart study. Circulation. 2007;116(11):1234-41.
16. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131-5.
17. Lear SA, Chen MM, Birmingham CL, Frohlich JJ. The relationship between simple anthropometric indices and C-reactive protein: Ethnic and gender differences. Metabolism. 2003;52(12): 1542-6.
18. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005;46(3):464-9.
19. Thorand B, Baumert J, Doring A, Herder C, Kolb H, Rathmann W, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006;184(1):216-24.
20. Khera A, Vega GL, Das SR, Ayers C, McGuire DK, Grundy SM, et al. Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab. 2009;94(9): 3251-8.
21. Bochud M, Marquant F, Marques-Vidal PM, Vollenweider P, Beckmann JS, Mooser V, et al. Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab. 2009;94(10):3969-77.
22. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study. Lancet. 2005; 366(9501):1954-9.
23. Welsh P, Polisecki E, Robertson M, Jahn S, Buckley BM, de Craen AJ, et al. Unraveling the directional link between adiposity and inflammation: A bidirectional Mendelian randomization approach. J Clin Endocrinol Metab. 2010;95(1):93-9.
24. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA. 2009;302(1):37-48.
25. Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health. 2006;6(9):9.
26. World Health Organization [Internet]. Geneva: Global physical activity surveillance. 2010 [updated 2010; cited 2010 Feb 25]. Available from: http://www.who.int/chp/steps/GPAQ/en/index.html.
27. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008;8:6.
28. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191-2.
29. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28(5):964-74.
30. Royston P, Sauerbrei W. Multivariable modeling: A pragmatic approach based on fractional polynomials for continuous variables. Chichester, UK: Wiley-Blackwell; 2008.
31. Abdullah SM, Khera A, Leonard D, Das SR, Canham RM, Kamath SA, et al. Sex differences in the association between leptin and CRP: Results from the Dallas Heart Study. Atherosclerosis. 2007;195(2):404-10.
32. Moshage HJ, Roelofs HM, van Pelt JF, Hazenberg BP, van Leeuwen MA, Limburg PC, et al. The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem Biophys Res Commun. 1988; 155(1):112-7.
33. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al. Subcutaneous adipose tissue releases interleukin- 6, but not tumor necrosis factor-Alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196-200.
34. Samara A, Herbeth B, Aubert R, Berrahmoune H, Fumeron F, Siest G, et al. Sex-dependent associations of leptin with metabolic syndrome-related variables: The Stanislas Study. Obesity. 2010;18(1):196-201.
35. Zhang YY, Gottardo L, Mlynarski W, Frazier W, Nolan D, Duffy J, et al. Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis. 2007;191(1):121-7.
36. Chen K, Li F, Li J, Cai H, Strom S, Bisello A, et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med. 2006;12(4):425-32.
37. Hukshorn CJ, Lindeman JH, Toet KH, Saris WH, Eilers PH, Westerterp-Plantenga MS, et al. Leptin and the proinflammatory state associated with human obesity. J Clin Endocrinol Metab. 2004;89(4):1773-8.